NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,820,548 | -36.8% | 116,047 | -37.3% | 0.23% | -38.7% |
| Q2 2023 | $18,691,156 | +7.1% | 185,226 | -2.3% | 0.38% | +1.9% |
| Q1 2023 | $17,447,892 | +933.4% | 189,651 | +919.0% | 0.37% | +687.2% |
| Q4 2022 | $1,688,390 | -88.8% | 18,611 | -90.6% | 0.05% | -88.1% |
| Q3 2022 | $15,089,000 | -17.0% | 198,515 | -7.7% | 0.40% | -11.0% |
| Q2 2022 | $18,178,000 | -16.1% | 215,050 | -12.9% | 0.44% | -4.3% |
| Q1 2022 | $21,676,000 | +10.3% | 247,016 | +9.9% | 0.46% | +8.2% |
| Q4 2021 | $19,652,000 | -0.8% | 224,666 | -7.3% | 0.43% | -0.2% |
| Q3 2021 | $19,811,000 | -7.9% | 242,252 | +2.7% | 0.43% | -10.0% |
| Q2 2021 | $21,517,000 | +13.0% | 235,822 | +7.8% | 0.48% | +6.0% |
| Q1 2021 | $19,038,000 | +44.5% | 218,770 | +56.7% | 0.45% | +33.0% |
| Q4 2020 | $13,174,000 | – | 139,611 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |